The Future Targeted Healthcare Manufacturing Hub at University College London will address manufacturing, business and regulatory challenges to ensure that new targeted biological medicines can be developed quickly and manufactured at a cost affordable to society.
The research will span stratified protein medicines targeted to particular patient groups through to truly personalised cell-based medicines.
Perceptive's PharmaMV platforms are deployed for researching new ways of improving pharma manufacturing efficiency and shortening time to market.